FlowMetric

Doylestown, United States Founded: 2010 • Age: 16 yrs Acquired By Kcas Bioanalytical Services
Preclinical studies, data analysis, and clinical testing services are provided.

About FlowMetric

FlowMetric is a Healthcare company based in Doylestown (United States) founded in 2010 by Renold J Capocasale, and was acquired by Kcas Bioanalytical Services in February 2022. Preclinical studies, data analysis, and clinical testing services are provided. FlowMetric has raised $3.95 million across 7 funding rounds from investors including European Union and Kcas Bioanalytical Services. Its chief executive, as recorded, is Renold J Capocasale. FlowMetric offers products and services including Flow Cytometry Services, Immunogenicity Testing, Large Molecule Bioanalysis, and Dose Formulation Analysis. Its focus areas include Biopharma Outsourcing, CRO and Diversified. Its competitors include Charles River Laboratories, LabCorp and Cytel; 1 of its 3 listed competitors has raised funding.

Company details

FlowMetric was established in 2010 in Doylestown, United States, as a contract research organization in the life sciences sector. Preclinical research, data analysis, clinical testing, and related services are offered to support pharmaceutical and biotechnology clients. Operations are centered in the U.S., with a focus on delivering analytical and testing solutions for drug development processes. Leadership is provided by founder Renold J. Capocasale as CEO.

  • Headquarters Doylestown, United States
  • Founders Renold J Capocasale
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website flowmetric.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Kcas Bioanalytical Services (Feb 2022)
Key Metrics

Products & Services of FlowMetric

FlowMetric offers a comprehensive portfolio of products and services, including Flow Cytometry Services, Immunogenicity Testing, Large Molecule Bioanalysis, and Dose Formulation Analysis.

Flow Cytometry Services
Analytical Services

Technique for cell analysis in clinical and research studies.

Immunogenicity Testing
Bioanalysis

Evaluates immune responses to therapeutic molecules.

Large Molecule Bioanalysis
Molecular Services

Analyzes large molecules in drug development processes.

Dose Formulation Analysis
Bioanalytical Services

Assesses formulation accuracy for clinical trials.

Apps and channels of FlowMetric

its YouTube channel KCAS Bio has 249 subscribers and 30 videos.

KCAS Bio
YouTube 249 subscribers 30 videos Science & Technology
Open channel

Videos from FlowMetric

The most watched videos on FlowMetric's YouTube channel, KCAS Bio (249 subscribers). Click a video to play it here.

KCAS Bio Lab Capabilities
302 views
The Conversational Flow 011 "Going Global with Spectral Flow Cytometry - US, EU and Now Australia"
80 views
The Conversational Flow 012 "High Content Analysis: Finding Needles in a Growing Haystack""
76 views
The Conversational Flow 015 "Fantastic Fluorophores and Where to Find Them (w/ Kelly Lundsten)"
70 views

More on KCAS Bio.

Funding Insights of FlowMetric

FlowMetric has successfully raised a total of $3.95M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $292.84 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.95M
  • Total Rounds 7
  • Last Round Grant β€” $292,841
  • First Round $1.5M

    (Jan 2011)

  • Investors Count 1

All 7 funding rounds of FlowMetric with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2019$292,841Grant––
Apr 2019$585,000Seed––
–
Jan 2017$820,000Seed––
–
Jun 2016$926,375Seed––
–
May 2013$25,000Seed––
–
Apr 2012$88,000Seed––
–
Jan 2011$1.5MSeed––
–
Valuation history

2 investors in total: 2 institutional.

Investors in FlowMetric

FlowMetric has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Kcas Bioanalytical Services.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Bioanalytical and immunoanalytical services are delivered by a diversified CRO.
2014kcasbio.comShawnee, United States
Premium access

Investor details for FlowMetric

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of FlowMetric

20 people are tracked at FlowMetric (8 in leadership, 12 in board & advisors).

NameRoleGroup
Renold J Capocasale
Founder & CEOLeadership
Brian Wile
General ManagerLeadership
Adam R. Cotty
Senior Director, Cellular & Flow Cytometry ServicesLeadership
Gianluca Carenzo
President, EULeadership
Mouhssin Oufir
General Manager, LyonLeadership
Alessandra Roberto
Lab Manager & Study DirectorLeadership
Jeff Goddard
Senior Vice President, Corporate DevelopmentLeadership
Maria Nelson
Chief Financial OfficerLeadership
Loretta Joseph
DirectorBoard & advisors
Raymond Douglas
DirectorBoard & advisors
Mark Rubin
DirectorBoard & advisors
Daniel Gambino
Board Of DirectorsBoard & advisors
Skip Wilday
DirectorBoard & advisors
Martin Smith
DirectorBoard & advisors
Frank Ricotta
DirectorBoard & advisors
Joe Carosella
DirectorBoard & advisors
Ben Sparango
DirectorBoard & advisors
JeanMarie Markham
DirectorBoard & advisors
Antonio Giordano
DirectorBoard & advisors
Jonni Moore
DirectorBoard & advisors
Premium access

Complete people profiles for FlowMetric

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of FlowMetric

4 dated milestones of FlowMetric across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded FlowMetric is founded.
  2. Funding First funding round of $1.5M.
  3. Funding Latest funding round, Grant, of $293K.
  4. Exit Acquired by Kcas Bioanalytical Services.

Competitors of FlowMetric

FlowMetric has 3 listed competitors in our database, 1 of them funded. They include Charles River Laboratories, LabCorp and Cytel.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
criver.com1947Wilmington, United States21,400
Provider of drug discovery and preclinical development services
labcorp.com1969Burlington, United States9,321
Provider of laboratory tests for physicians
cytel.com1987Cambridge, United States$2M509
Data analysis and statistical solutions are provided for life sciences.
Premium access

Detailed competitors of FlowMetric

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as FlowMetric (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Flowmetric

Premium access

Complete news archive for FlowMetric

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FlowMetric

FlowMetric was founded in 2010 and raised its 1st funding round 1 year after it was founded.

FlowMetric is headquartered in Doylestown, United States. It is registered at Doylestown, Pennsylvania, United States.

Renold J Capocasale is the CEO of FlowMetric, as recorded in our data. They have also founded this company.

FlowMetric is a funded company, having raised a total of $3.95M across 7 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Jan 2011.

FlowMetric was established in 2010 in Doylestown, United States, as a contract research organization in the life sciences sector. Preclinical research, data analysis, clinical testing, and related services are offered to support pharmaceutical and biotechnology clients. Operations are centered in the U.S., with a focus on delivering analytical and testing solutions for drug development processes. Leadership is provided by founder Renold J. Capocasale as CEO.

FlowMetric's top competitors include LabCorp, Charles River Laboratories and Cytel.

FlowMetric offers Flow Cytometry Services, Immunogenicity Testing, Large Molecule Bioanalysis, and Dose Formulation Analysis.

FlowMetric has 2 investors. Key investors include European Union, and Kcas Bioanalytical Services.

Yes. FlowMetric was acquired by Kcas Bioanalytical Services in February 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available